Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Diving Into the in Vivo Noradrenergic System : Role of the alpha2C-adrenergic Receptors

Authors not listed

Hospices Civils de Lyon · 2026

Abstract

The main goal of this research proposal is to provide, for the first time in humans, a wider understanding of the role of the noradrenergic system both in health and illness (here Parkinson's disease) through the use of a newly developed radiotracer visualizing alpha2C-ARs (\[11C\]ORM-13070) combined with a cutting-edge technology, the hybrid PET/MRI scanner. The secondary aim will be to determine whether the expected age- and PD-related changes in the noradrenergic system are paralleled by changes in neuropsychological performances (i.e. cognitive, motor and/or olfactory abilities).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-06 MST

Cite this

APA
Anonymous. (2026). Diving Into the in Vivo Noradrenergic System : Role of the alpha2C-adrenergic Receptors. <em>Hospices Civils de Lyon</em>. https://clinicaltrials.gov/study/NCT07569120
Vancouver
Anonymous. Diving Into the in Vivo Noradrenergic System : Role of the alpha2C-adrenergic Receptors. Hospices Civils de Lyon. 2026.
BibTeX
@misc{anon2026Diving, title = {Diving Into the in Vivo Noradrenergic System : Role of the alpha2C-adrenergic Receptors}, author = {Anonymous}, journal = {Hospices Civils de Lyon}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings